Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium orotate is a small molecule mineral supplement developed by West Bengal Chemical Industries Limited (WBCIL). It is the calcium salt of orotic acid (historically known as Vitamin B13), which serves as a biochemical carrier to enhance the bioavailability and cellular uptake of calcium ions. By facilitating the transport of calcium across biological membranes, it is intended to support bone density, cardiovascular health, and cellular signaling more effectively than traditional calcium salts like carbonate or citrate. WBCIL, an Indian manufacturer of APIs and fine chemicals, lists the product as being in development for use as a nutritional supplement and pharmaceutical ingredient to address calcium deficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium orotate.